Photon Raises $16M in Series A Funding Led by Healthier Capital

The company plans to use the funds to grow its engineering and commercial teams and expand integrations with health systems and platforms.

Electronic prescribing made it easier for doctors to write prescriptions, but it created a problem for patients. When a prescription is written, patients must quickly choose a pharmacy without knowing prices, availability, or convenience. This often leads to transfers, calls, and delays for everyone involved. Photon was built to fix this problem at the source.

Photon is rebuilding the prescription process into a complete end-to-end platform, combining modern prescribing and routing systems with a network of retail and home-delivery pharmacies, a consumer marketplace showing real-time prices and availability, and additional features such as prior authorization and clinical decision support to improve the overall experience.

By integrating at the point of prescribing, Photon lets patients choose a pharmacy with real information on price, availability and convenience before the prescription is sent. This brings much needed transparency to a key moment in healthcare and helps patients make better decisions.

For health systems the platform turn's prescriptions into a patient engagement tool giving pharmacy teams real time visibility and helping guide patients on options like delivery and price. Artificial intelligence (AI) powers this by processing complex data from pharmacy networks and insurance system's in real time reducing abandoned prescriptions minimizing delay's and improving the overall experience.

Photon started in direct to consumer digital health, building prescription infrastructure for fast growing brands, and has since expanded into health systems with its patient-first platform and deep pharmacy integrations. Since its founding in 2021, Photon has helped millions of patients make better pharmacy choices. After raising $9M in July 2024, it is now focused on expanding integrations, growing health system partnerships and improving access, and control for more patients.

Photon aims to go beyond improving prescriptions by building long-term infrastructure that reduces strain across the healthcare system—for doctors, pharmacies, health systems, and patients. Its AI helps identify patterns, predict issues early, and solve root problems, making the system more efficient and giving patients a more active role in their care.

Read More:DISA Technologies Raises $33M in Funding

"We're building prescription infrastructure for the AI era. We're scaling at a critical juncture where LLMs and agentic workflows are disrupting healthcare SaaS and services — right as healthcare affordability and consumer demand for transparency reach a boiling point. We're leveraging this technology to empower consumers, enable true price transparency, and push the pharmacy industry back toward an open marketplace," says Otto Sipe, Photon founder and CEO.

"We are delighted to partner with Photon to modernize the prescription process delivering an improved experience for patients while reducing friction across the entire healthcare system, said Amir Dan Rubin, Founder and Managing Partner Healthier Capital.

About Photon

Founded in 2021, by Otto Sipe, Sam Kotlove and Michael Rado, Photon provides an end-to-end prescription platform for modern healthcare. It combines digital prescribing tools, pharmacy integrations, and a consumer marketplace to give patients real time information when choosing a pharmacy. The platform also helps providers reduce administrative work, support patient workflows and improve medication access and adherence across the care journey.

Read More:Iterative Health Raises $77M in Series C Funding